These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1948784)

  • 1. Use of Rabenid for different indications.
    Nagy F
    Ther Hung; 1991; 39(2):90-2. PubMed ID: 1948784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations with Rabenid in patients with locomotor disease.
    Konrád K
    Ther Hung; 1989; 37(2):99-102. PubMed ID: 2686087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Uricosuric agents: Should they be used in asymptomatic hyperuricemia?].
    Naess K
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):45-6. PubMed ID: 1257956
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men.
    Desai MY; Santos RD; Dalal D; Carvalho JA; Martin DR; Flynn JA; Nasir K; Blumenthal RS
    Am J Cardiol; 2005 Apr; 95(7):865-8. PubMed ID: 15781018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new therapeutic approach of associated metabolic diseases. 1 000 patients treated with benfluorex (author's transl)].
    Glikmanas M; Giraudet MC; Fould G
    Sem Hop; 1979 Sep 8-15; 55(27-30):1305-11. PubMed ID: 228405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of hyperuricemia caused by fructose in a status of altered uric acid metabolism].
    Menghini S; Della Corte E
    Quad Sclavo Diagn; 1987 Dec; 23(4):441-6. PubMed ID: 3509875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outpatient care in uric acid disorders].
    Schwenke R; Altus RE; Kirschner I
    Z Gesamte Inn Med; 1979 Aug; 34(16):454-7. PubMed ID: 539007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the influence of Anturan on ric acid and plasma lipids in patients with gout].
    Günther R; Herbst M; Knapp E; Siller K
    Wien Klin Wochenschr; 1968 Jun; 80(24):473-8. PubMed ID: 5692866
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interaction of sulfinpyrazone (Anturan) and glibenclamide (Euglucon) in type II diabetic patients].
    Kritz H; Najemnik C; Irsigler K
    Wien Med Wochenschr; 1983 May; 133(9):237-43. PubMed ID: 6408808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
    Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
    Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of sulfinpyrazone on peritoneal and renal clearance in patients with chronic renal failure treated by intermittent peritoneal dialysis].
    Grzegorzewska A; Antoniewicz K; Kuźniak J; Zawadzka E
    Przegl Lek; 1990; 47(10):686-90. PubMed ID: 2089444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
    Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J
    Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigations concerning the incidence of disorders of lipid and carbohydrate metabolism in primary gout and symptomless hyperuricaemia (author's transl)].
    Frank O
    Wien Klin Wochenschr; 1974 May; 86(9):252-6. PubMed ID: 4363464
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical study of hyperuricaemic men.
    Laing JK
    N Z Med J; 1975 Dec; 82(554):408-10. PubMed ID: 1062724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden.
    Bengtsson C; Lapidus L; Stendahl C; Waldenström J
    Acta Med Scand; 1988; 224(6):549-55. PubMed ID: 3207067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Longitudinal study of uric acid changes in a constant group from 1968-78].
    Reuter W; Sauer I
    Z Gesamte Inn Med; 1980 Sep; 35(17):681-3. PubMed ID: 7467591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the hypouricemic effects of calcitonin and sulfinpyrazone].
    Rico Lenza H; Huertas García-Alejo R; del Río Vázquez A; Espinós Pérez D
    Rev Clin Esp; 1982 Feb; 164(4):249-52. PubMed ID: 6283606
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid.
    Lin JD; Chiou WK; Chang HY; Liu FH; Weng HF
    Metabolism; 2007 Jun; 56(6):751-6. PubMed ID: 17512306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid concentration as a risk factor for cardiovascular mortality: a longterm cohort study of atomic bomb survivors.
    Hakoda M; Masunari N; Yamada M; Fujiwara S; Suzuki G; Kodama K; Kasagi F
    J Rheumatol; 2005 May; 32(5):906-12. PubMed ID: 15868629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.